IP Verse

Solid Compositions Comprising A Glp-1 Agonist, A Salt Of N-(8-(2-Hydroxybenzoyl)Amino)Caprylic Acid And A Lubricant

Patent No. EP3746111 (titled "Solid Compositions Comprising A Glp-1 Agonist, A Salt Of N-(8-(2-Hydroxybenzoyl)Amino)Caprylic Acid And A Lubricant") was filed by Novo Nordisk on Feb 1, 2019. The application was issued on Jul 19, 2023.

Patent Summary

A pharmaceutical composition comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid, wherein the composition comprises at least one granule comprising said salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid, and wherein the at least one granule is prepared by dry granulation, such as by roller compaction.

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
HEXALApr 19, 2024MAIWALD
HOEFER & PARTNER PATENTANWALTE MBBApr 18, 2024HOEFER & PARTNER PATENTANWALTE MBB
KRAUS & LEDERER PARTGMBBApr 18, 2024KRAUS & LEDERER PARTGMBB
ACAPOApr 17, 2024ACAPO
ACAPO ONSAGERSApr 17, 2024ACAPO

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3746111

NOVO NORDISK
Application Number
EP19702275A
Filing Date
Feb 1, 2019
Status
Granted And Under Opposition
Jun 16, 2023
Publication Date
Jul 19, 2023
External Links
Slate, Register , Google Patents